Podcast from Opportunities in Proton Therapy: Head and Neck

Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 24 de abril del 2007

Share article


Imprima English

OncoLink Podcast

Subscribe to OncoLink Podcasts Subscribe to OncoLink Podcasts on iTunes

You may also use Quicktime to view the individual presentation:

Head and Neck
Robert Malyapa, M.D., Assistant Professor, Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL

iTunes Manual Instructions:

  1. Click Advanced
  2. Subscribe to Podcast
  3. Add URL http://tv.oncolink.org/Podcasts/podcasts.xml

Imprima English
News
AACR: New Drug May Add to Therapy for Head and Neck CA

Today - The investigational drug alpelisib (previously known as BYL719) appears to inhibit activation of the pathway that leads to resistance to cetuximab, an anti-epidermal growth factor receptor agent used in the treatment of head and neck cancer. These findings were presented at the American Association for Cancer Research's special conference "Targeting the PI3K-mTOR Network in Cancer," held from Sept. 14 to 17 in Philadelphia.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información